MedTrace Logo

Pre- and Post-TAVI Patient Assessment: Advancing Outcome Precision in Aortic Valve Therapy

NCT07179302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-12-03

No results posted yet for this study

Summary

The aim of this study is to evaluate the combined utility of the left atrial coupling index (LACI) and left ventricular speckle tracking echocardiography (LVSTE) in improving risk stratification and outcome prediction for patients undergoing Transcatheter Aortic Valve Implantation (TAVI). This study seeks to identify novel prognostic markers that enhance the prediction of mortality, heart failure, and functional recovery, ultimately enabling more personalized clinical decision-making and optimized patient outcomes by integrating the advanced echocardiographic parameters into pre-procedural assessments,.

Conditions

  • Aortic Valve Stenosis

Interventions

PROCEDURE

Transcatheter Aortic Valve Implantation (TAVI)

evaluate the role of the left atrial coupling index (LACI) and left ventricular speckle tracking echocardiography (LVSTE) in enhancing outcome prediction in patients undergoing TAVI.

Sponsors & Collaborators

  • medina medical center

    collaborator OTHER

  • Tanta University

    collaborator OTHER

  • Damanhour University

    lead OTHER

Principal Investigators

  • Eman Elshaikh, Ass Prof. · Madina Cardiac Center, KSA

Eligibility

Min Age
50 Years
Max Age
102 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2025-10-30
Completion
2025-11-01

Countries

  • Egypt
  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07179302 on ClinicalTrials.gov